Cancer patient advocacy: New opportunities for treatment advances

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 4, 2007, Pages 351-352

  Quale, Diane Zipursky ^a   Droller, Michael J ^b  

^a Bladder Cancer Advocacy Network   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Advocacy; Bladder cancer; Clinical trials

Indexed keywords

AWARENESS; BLADDER CANCER; BREAST CANCER; CANCER PATIENT; CANCER RESEARCH; CANCER SCREENING; CANCER SURGERY; CANCER THERAPY; FUNDING; GOVERNMENT; HEALTH CARE PERSONNEL; HUMAN; OUTCOME ASSESSMENT; PATIENT ADVOCACY; PATIENT EDUCATION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW;

HEALTH POLICY; HUMANS; PATIENT ADVOCACY; URINARY BLADDER NEOPLASMS;

EID: 34447093809     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.05.001     Document Type: Review

References (0)